Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
-32.24%
OPERATING MARGIN AVG 20Y
-43.39%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Achieve Life Sciences, Inc.
Market Cap
$738.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$746.62M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6934.80%
5Y Avg
-9894.67%
Market Cap
$725.14M
Operating Margin
-21.60%
TTM Avg
-15.14%
3Y Avg
-11.45%
5Y Avg
-3.99%
Market Cap
$752.35M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$723.66M
Operating Margin
-123601.69%
TTM Avg
-69568.65%
3Y Avg
-35191.57%
5Y Avg
-23714.64%
Market Cap
$719.02M
Operating Margin
19.61%
TTM Avg
25.44%
3Y Avg
21.88%
5Y Avg
18.67%
Market Cap
$712.76M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$764.79M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$778.67M
Operating Margin
9.00%
TTM Avg
7.11%
3Y Avg
-27.53%
5Y Avg
-16.39%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Achieve Life Sciences, Inc. (ACHV) | $738.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Candel Therapeutics, Inc. (CADL)vs › | $746.62M | 0.00% | 0.00% | -6934.80% | -9894.67% |
| Cytek Biosciences, Inc. (CTKB)vs › | $725.14M | -21.60% | -15.14% | -11.45% | -3.99% |
| Faeth Therapeutics, Inc. (FTH)vs › | $752.35M | 0.00% | 0.00% | 0.00% | 0.00% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $723.66M | -123601.69% | -69568.65% | -35191.57% | -23714.64% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $719.02M | 19.61% | 25.44% | 21.88% | 18.67% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $712.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Design Therapeutics, Inc. (DSGN)vs › | $764.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mesa Laboratories, Inc. (MLAB)vs › | $778.67M | 9.00% | 7.11% | -27.53% | -16.39% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $778.76M | -4974.74% | -2487.37% | -2487.37% | -2487.37% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | -300.75% |
| 2016-03-31 | -150.75% |
| 2015-12-31 | -57.74% |
| 2015-09-30 | -69.63% |
| 2015-06-30 | -138.81% |
| 2015-03-31 | -363.68% |
| 2014-12-31 | -117.90% |
| 2014-09-30 | -102.17% |
| 2014-06-30 | -154.80% |
| 2014-03-31 | -67.59% |
| 2013-12-31 | -81.79% |
| 2013-09-30 | -107.64% |
| 2013-06-30 | -148.20% |
| 2013-03-31 | -163.10% |
| 2012-12-31 | -41.95% |
| 2012-09-30 | -126.18% |
| 2012-06-30 | -244.71% |
| 2012-03-31 | -418.16% |
| 2011-12-31 | -644.98% |
| 2011-09-30 | -348.98% |
| 2011-06-30 | -264.60% |
| 2011-03-31 | -435.78% |
| 2010-12-31 | -82.05% |
| 2010-09-30 | -142.33% |
| 2010-06-30 | -167.31% |
| 2010-03-31 | -64.47% |
| 2009-12-31 | 26.94% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | -24.42% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 19.87% |
| 2007-09-30 | -155.75% |
| 2007-06-30 | -200.35% |
| 2007-03-31 | -76.50% |
| 2006-12-31 | -130.70% |
| 2006-09-30 | -144.71% |
| 2006-06-30 | -74.83% |
| 2006-03-31 | -143.70% |
| 2005-12-31 | -0.05% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | -2.06% |
| 2004-09-30 | -4629.27% |
| 2004-06-30 | -6881.23% |
| 2004-03-31 | -10096.03% |
| 2003-12-31 | -1.55% |
| 2003-09-30 | -6419.63% |
| 2003-06-30 | -10291.35% |
| 2003-03-31 | -9336.33% |
| 2002-12-31 | 909.90% |
| 2002-09-30 | -3247.61% |
